<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04889456</url>
  </required_header>
  <id_info>
    <org_study_id>2021.0273</org_study_id>
    <nct_id>NCT04889456</nct_id>
  </id_info>
  <brief_title>Standardizing Right Hemicolectomy for Colon Cancer</brief_title>
  <acronym>Right</acronym>
  <official_title>Implementation of Optimized and Standardized Surgical Technique for Right Sided Colon Cancer: a Prospective Interventional Sequential Cohort Study With a Transition Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Prof. dr. P.J. Tanis, colorectal surgeon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. B.R. Toorenvliet, colorectal surgeon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>D. Miskovic, St Marks hospital London, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>S. Benz, Klinikverbund SuedWest, Böblingen, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Drs. A.A.J. Grüter</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. U.K. Coblijn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. H.L. van Westreenen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. C. Sietses</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prof. dr. E.C.J. Consten</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. A.W.H. van de Ven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. P. van Duijvendijk</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. S. van Aalten</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. F. den Boer</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. J.W.A. Leijtens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. C. Hoff</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. O. van Ruler</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dr. G. D. Slooter</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prof. dr. J. Lange</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prof. dr. G.J. Kleinrensink</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VU University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A surgical intervention might be highly variable amongst surgeons and centers. This&#xD;
      variability has a potential relevance concerning clinical outcomes.&#xD;
&#xD;
      For right-sided colon cancer, the laparoscopic right hemicolectomy (LRHC) knows substantial&#xD;
      variation. Especially since the surgical technique has been evolving during the latest decade&#xD;
      with the introduction of intracorporeal anastomosis, a dissection technique within the&#xD;
      correct embryological planes (complete mesocolic excision) and central vascular ligation of&#xD;
      the segmental branches at its origin, resulting in an optimal lymph node dissection.&#xD;
&#xD;
      Given the insights from recent studies showing the association between quality of surgery and&#xD;
      relevant clinical outcomes, there is a great need for a formative quality assessment of LRHC.&#xD;
      Detailed objective assessment of the LRHC is currently not performed in clinical practice nor&#xD;
      in surgical training. Quality assessment of LRHC has great potential to improve surgical&#xD;
      training and furthermore, implementation of a standardized technique will ultimately lead to&#xD;
      better quality of care for patients suffering from right-sided colon cancer.&#xD;
&#xD;
      The main objective of this study is to improve surgical outcomes for patient with right-sided&#xD;
      colon cancer by a prospective sequential interventional cohort study that aims to standardize&#xD;
      the surgical technique with subsequent controlled implementation after standardized review of&#xD;
      the current practice in a nationwide multicenter setting. The primary endpoint is the 30-day&#xD;
      morbidity according to the Clavien-Dindo classification system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Prospective mapping of current practice with surgical variations in laparoscopic right&#xD;
           hemicolectomy (total duration of inclusion 3 months) N= 40 centers N = 310 videos&#xD;
&#xD;
             1. METC approval for the use of anonymized videos of a laparoscopic procedure and&#xD;
                collection of corresponding clinical outcomes.&#xD;
&#xD;
             2. Approaching hospitals for participation (high volume centers (50+ colon cancers).&#xD;
&#xD;
             3. Prospective inclusion of consecutive patients undergoing laparoscopic right&#xD;
                hemicolectomy in the participating hospitals in three months.&#xD;
&#xD;
        2. Development of Standard Laparoscopic Right Hemicolectomy: an (inter)national Delphi&#xD;
           study&#xD;
&#xD;
             1. Approaching specialists to participate in the Delphi method (from participating&#xD;
                hospitals in step 1).&#xD;
&#xD;
             2. Identification of crucial steps and measures according to literature and expert's&#xD;
                opinion (Delphi method).&#xD;
&#xD;
             3. Documentation of steps and the order in which they need to be performed,&#xD;
                development of a competency assessment tool (CAT).&#xD;
&#xD;
        3. Skills center training facility&#xD;
&#xD;
           a. Training the participating surgeons in the method of the standardized laparoscopic&#xD;
           right hemicolectomy, as consented in the Delphi method.&#xD;
&#xD;
        4. Implementation of the standardized laparoscopic right hemicolectomy with proctoring&#xD;
           during another period with prospective inclusion of consecutive patients with collection&#xD;
           of surgical videos in all participating hospitals (N=40 centers, total 310 videos)&#xD;
&#xD;
             1. Rating videos.&#xD;
&#xD;
             2. Comparing with pre-implementation performance based on outcome measures reflecting&#xD;
                oncological quality of surgery, and 30-day clinical outcomes.&#xD;
&#xD;
             3. Comparing with pre-implementation performance based on the long-term outcomes.&#xD;
                (3-year DFS and 5-year OS).&#xD;
&#xD;
        5. Implementing standardised lap right hemicolectomy (after learning curve without&#xD;
           proctoring)&#xD;
&#xD;
             1. Consecutive inclusion of patients (n=310)&#xD;
&#xD;
             2. CT imaging&#xD;
&#xD;
             3. Video analysis&#xD;
&#xD;
             4. Competency analysis&#xD;
&#xD;
             5. Variation analysis&#xD;
&#xD;
             6. Clinico pathological data&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>A prospective interventional sequential cohort study with a transition period</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30-day morbidity with Clavien-Dindo grading</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications (i.e. vascular injury)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion rate from laparoscopic to open surgery</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validated assessment of plane of dissection</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validated assessment of level of vascular ligation</measure>
    <time_frame>1 day</time_frame>
    <description>Assessment according to a competency assessment tool (CAT) for laparoscopic right hemicolectomy. This tool will be created during phase 2 using the Delphi method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grading of the resection specimen according to Benz et al. 2019</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total lymph node count</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of resected positive lymph nodes</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resection margins</measure>
    <time_frame>1 day</time_frame>
    <description>Radicality of resection margin of the specimen, as assessed by the pathologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completeness of mesocolic excision based on postoperative CT imaging</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Locoregional recurrence</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant metastasis</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year disease free survival (DFS)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5-year overall survival (OS)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term morbidity: incisional hernia, adhesion related small bowel obstruction, readmissions, reinterventions</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">930</enrollment>
  <condition>Colonic Carcinoma</condition>
  <condition>Laparoscopic Right Hemicolectomy</condition>
  <condition>Standardisation</condition>
  <condition>Training</condition>
  <condition>Delphi Study</condition>
  <condition>Implementation</condition>
  <condition>Consolidation</condition>
  <condition>Assessment</condition>
  <arm_group>
    <arm_group_label>Surgical variations laparoscopic right hemicolectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Implementing standardised laparoscopic right hemicolectomy with proctoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Implementing standardised laparoscopic right hemicolectomy without proctoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implementation standardised laparoscopic right hemicolectomy with proctoring</intervention_name>
    <description>Implementation standardised laparoscopic right hemicolectomy with proctoring</description>
    <arm_group_label>Implementing standardised laparoscopic right hemicolectomy with proctoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implementation standardised laparoscopic right hemicolectomy without proctoring</intervention_name>
    <description>Implementation standardised laparoscopic right hemicolectomy without proctoring</description>
    <arm_group_label>Implementing standardised laparoscopic right hemicolectomy without proctoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned laparoscopic (extended) right hemicolectomy for colon cancer of the caecum,&#xD;
             ascending colon or hepatic flexure;&#xD;
&#xD;
          -  Age above 18 years;&#xD;
&#xD;
          -  cTNM stage 1-3 (CT-staged);&#xD;
&#xD;
          -  No prior midline or transverse laparotomy;&#xD;
&#xD;
          -  ASA1-3;&#xD;
&#xD;
          -  No immune modulating medication.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cT4b;&#xD;
&#xD;
          -  Perforated disease;&#xD;
&#xD;
          -  Acute obstruction;&#xD;
&#xD;
          -  Emergency operation;&#xD;
&#xD;
          -  Appendiceal cancer;&#xD;
&#xD;
          -  Other primary malignancy treated within 5 years from diagnosis of colon cancer, except&#xD;
             for curatively treated prostate, breast, skin and cervical cancer.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Amsterdam UMC, location VUmc</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexander A.J. Grüter, MD</last_name>
      <phone>+316 45552015</phone>
      <email>alexandergruter@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Usha K. Coblijn, MD, PhD</last_name>
      <phone>+316 43469794</phone>
      <email>usha.coblijn@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jurriaan B. Tuynman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pieter J. Tanis, MD, PhD, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boudewijn R. Toorenvliet, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>Jurriaan B. Tuynman</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

